Treatable traits in bronchiectasis
- 6 September 2018
- journal article
- editorial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 52 (3), 1801269
- https://doi.org/10.1183/13993003.01269-2018
Abstract
A treatment approach based on “treatable traits” may provide better outcomes in the treatment of bronchiectasis http://ow.ly/ywaF30l71OGKeywords
Funding Information
- British Lung Foundation (GSK/BLF Chair of Respiratory Research)
- European Respiratory Society (EMBARC2, Short term research Fellowship to OS)
This publication has 46 references indexed in Scilit:
- Bronchiectasis: how to be an orphan with many parents?European Respiratory Journal, 2015
- Airway clearance techniques for bronchiectasisCochrane Database of Systematic Reviews, 2015
- A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthmaEuropean Respiratory Journal, 2015
- Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort studyEuropean Respiratory Journal, 2015
- COPD–bronchiectasis overlap syndromeEuropean Respiratory Journal, 2015
- Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trialThorax, 2014
- Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsThe Lancet Respiratory Medicine, 2014
- Chronic Obstructive Pulmonary Disease PhenotypesAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous diseaseThe Lancet, 2008
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007